These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38542188)

  • 61. Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming.
    Shao X; Zhang C; Sun MA; Lu X; Xie H
    BMC Genomics; 2014 Nov; 15(1):978. PubMed ID: 25404570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.
    Vitaloni M; Pulecio J; Bilic J; Kuebler B; Laricchia-Robbio L; Izpisua Belmonte JC
    J Biol Chem; 2014 Jan; 289(4):2084-98. PubMed ID: 24311783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neural stem cells achieve and maintain pluripotency without feeder cells.
    Choi HW; Kim JS; Choi S; Jang HJ; Kim MJ; Choi Y; Schöler HR; Chung HM; Do JT
    PLoS One; 2011; 6(6):e21367. PubMed ID: 21738644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.
    Stricker SH; Feber A; Engström PG; Carén H; Kurian KM; Takashima Y; Watts C; Way M; Dirks P; Bertone P; Smith A; Beck S; Pollard SM
    Genes Dev; 2013 Mar; 27(6):654-69. PubMed ID: 23512659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.
    Lin YC; Murayama Y; Hashimoto K; Nakamura Y; Lin CS; Yokoyama KK; Saito S
    Stem Cell Res Ther; 2014; 5(2):58. PubMed ID: 25157408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
    Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
    Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
    Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming.
    Huang P; Zhu J; Liu Y; Liu G; Zhang R; Li D; Pei D; Zhu P
    Stem Cell Rev Rep; 2021 Dec; 17(6):2223-2234. PubMed ID: 34448118
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cellular trajectories and molecular mechanisms of iPSC reprogramming.
    Apostolou E; Stadtfeld M
    Curr Opin Genet Dev; 2018 Oct; 52():77-85. PubMed ID: 29925040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells.
    Nissenbaum J; Bar-Nur O; Ben-David E; Benvenisty N
    Stem Cell Reports; 2013; 1(6):509-17. PubMed ID: 24371806
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
    Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
    J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood.
    Szablowska-Gadomska I; Sypecka J; Zayat V; Podobinska M; Pastwinska A; Pienkowska-Grela B; Buzanska L
    Acta Neurobiol Exp (Wars); 2012; 72(4):337-50. PubMed ID: 23377265
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DNA hypermethylation in somatic cells correlates with higher reprogramming efficiency.
    Barrero MJ; Berdasco M; Paramonov I; Bilic J; Vitaloni M; Esteller M; Izpisua Belmonte JC
    Stem Cells; 2012 Aug; 30(8):1696-702. PubMed ID: 22653871
    [TBL] [Abstract][Full Text] [Related]  

  • 79. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.
    Chen J; Liu H; Liu J; Qi J; Wei B; Yang J; Liang H; Chen Y; Chen J; Wu Y; Guo L; Zhu J; Zhao X; Peng T; Zhang Y; Chen S; Li X; Li D; Wang T; Pei D
    Nat Genet; 2013 Jan; 45(1):34-42. PubMed ID: 23202127
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
    Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.